Literature DB >> 19887841

Prevalence and risk factors of somatic and autonomic neuropathy in prediabetic and diabetic patients.

Wei-Chih Hsu1, Amy Ming-Fang Yen, Horng-Huei Liou, Han-Cheng Wang, Tony Hsiu-Hsi Chen.   

Abstract

AIMS/HYPOTHESIS: To investigate the prevalence and correlates of somatic and autonomic neuropathies concurrently in prediabetic and diabetic subjects in the general population. SUBJECTS AND METHODS: Nerve conduction and heart rate variability studies were used for detecting both types of diabetic neuropathy. Of 1,576 inhabitants, 143 persons were identified as prediabetic or having diabetic mellitus. One hundred and thirty-three persons completed a nerve conduction test and 118 persons a valid heart rate variability test. Significant correlates responsible for diabetic neuropathies were also collected.
RESULTS: The prevalence rates of definite, probable and no somatic neuropathy were 9.0% (12/133), 20.3% (27/133) and 70.7% (94/133), respectively. The corresponding figures for autonomic neuropathy were 14.4% (17/118), 54.2% (64/118) and 31.4% (37/118). The prevalence rate for the presence of both neuropathies was 16.9%. In a univariate analysis, age, renal insufficiency, HbA1c and fasting glucose level were significantly associated with somatic neuropathy whereas only systolic blood pressure was statistically significantly associated with autonomic neuropathy. In a multivariate analysis, systolic blood pressure and fasting glucose level were positively associated with somatic neuropathy and systolic blood pressure remained statistically significant for autonomic neuropathy.
CONCLUSIONS: The prevalence of autonomic neuropathy is twofold compared with somatic neuropathy. Concurrence of the two kinds of neuropathy was approximately half of sole somatic neuropathy and a quarter of sole autonomic neuropathy. Systolic blood pressure and fasting glucose level were related to somatic neuropathy whereas only systolic blood pressure was correlated with autonomic neuropathy. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19887841     DOI: 10.1159/000254571

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  7 in total

1.  Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey.

Authors:  Dan Ziegler; Andreas Voss; Wolfgang Rathmann; Alexander Strom; Siegfried Perz; Michael Roden; Annette Peters; Christa Meisinger
Journal:  Diabetologia       Date:  2015-02-28       Impact factor: 10.122

2.  Cardiac sympathetic imaging in the diagnosis of cardiac autonomic neuropathy in pre-diabetes.

Authors:  Fahad Waqar; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2015-03-05       Impact factor: 5.952

3.  [Impairment of cardiac autonomic nervous system and incidence of arrhythmias in severe hyperglycemia].

Authors:  Sven Süfke; Hasib Djonlagić; Thomas Kibbel
Journal:  Med Klin (Munich)       Date:  2011-01-16

4.  Adding pregabalin or gabapentin for the management of community-treated patients with painful diabetic peripheral neuropathy: a comparative cost analysis.

Authors:  Antoni Sicras; Javier Rejas; Ruth Navarro; Albert Planas
Journal:  Clin Drug Investig       Date:  2013-11       Impact factor: 2.859

5.  Cardiovascular autonomic neuropathy in people with type 2 diabetes mellitus; investigation of its association with classical cardiovascular risk factors using cardiovascular autonomic reflex tests: a cross-sectional study.

Authors:  Ahmad Osailan
Journal:  Egypt Heart J       Date:  2021-05-13

6.  Accuracy of a Novel Non-Invasive technology based EZSCAN system for the diagnosis of diabetes mellitus in Chinese.

Authors:  Chang-Sheng Sheng; Wei-Fang Zeng; Qi-Fang Huang; Jean-Paul Deslypere; Yan Li; Ji-Guang Wang
Journal:  Diabetol Metab Syndr       Date:  2011-12-22       Impact factor: 3.320

7.  Blood pressure variability and its association with echocardiographic parameters in hypertensive diabetic patients.

Authors:  Daniela Massierer; Liana Farias Leiria; Mateus Dorneles Severo; Priscila Dos Santos Ledur; Alexandre Dalpiaz Becker; Fernanda Mus Aguiar; Eliandra Lima; Valéria Centeno Freitas; Beatriz D Schaan; Miguel Gus
Journal:  BMC Cardiovasc Disord       Date:  2016-01-08       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.